CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoRASCHI, EMANUEL
Dettaglio
RASCHI, EMANUEL
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Pubblicazioni
Risultati 1 - 20 di 122 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis | Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, ...Fabrizio; Bégaud, Bernard; Pariente, Antoine | 2016 | BMJ BRITISH MEDICAL JOURNAL | 1.01 Articolo in rivista | ||
| 2 | Advancements in drug development for diarrhea-predominant irritable bowel syndrome | Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio* | 2018 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 1.01 Articolo in rivista | - | |
| 3 | Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies | Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; ...Poluzzi, E. | 2015 | CEPHALALGIA | 1.01 Articolo in rivista | - | |
| 4 | Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications | Raschi, Emanuel; Bianchin, Matteo; Ageno, Walter; De Ponti, Roberto; De Ponti, Fabrizio | 2016 | POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 1.01 Articolo in rivista | - | |
| 5 | Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
| 6 | Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi | 2020 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 1.01 Articolo in rivista | ||
| 7 | Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1.01 Articolo in rivista | - | |
| 8 | Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system | Mazzanti, Gabriela; Moro, Paola Angela; Raschi, Emanuel; Da Cas, Roberto; Menniti-Ippolito, Franc...esca | 2017 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
| 9 | Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. | Raschi, E; Vasina, V; Ursino, M G; Boriani, G; Martoni, A; De Ponti, F | 2010 | PHARMACOLOGY & THERAPEUTICS | 1.01 Articolo in rivista | - | |
| 10 | Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2009 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 1.01 Articolo in rivista | - | |
| 11 | Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2010 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
| 12 | Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. | Poluzzi E;Raschi E;Koci A;Moretti U;Spina E;Behr ER;Sturkenboom M;De Ponti F | 2013 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
| 13 | Apparato Gastroenterico | E. Raschi; E. Poluzzi | 2011 | Elsevier | 5.02 Contributo in volume (Traduzione) | - | |
| 14 | Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy | Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli,... Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco | 2016 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | 1.01 Articolo in rivista | - | |
| 15 | Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. | Bennie M;Bishop I;Godman B;Barbui C;Raschi E;Campbell S;Miranda J;Gustafsson LL | 2013 | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 1.01 Articolo in rivista | - | |
| 16 | Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database | Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Caraceni, Paolo; De Ponti, Fabrizio | 2014 | WORLD JOURNAL OF HEPATOLOGY | 1.01 Articolo in rivista | - | |
| 17 | Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review | Gatti M.; Bianchin M.; Raschi E.; De Ponti F. | 2020 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | 1.01 Articolo in rivista | - | |
| 18 | Association between the use of proton pump inhibitors and cardiovascular events: A note of caution | Raschi, E.; Bianchin, M.; Poluzzi, E.; De Ponti, F | 2017 | NEUROGASTROENTEROLOGY AND MOTILITY | 1.04 Replica / breve intervento (e simili) | - | |
| 19 | Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies | Diemberger, Igor; Raschi, Emanuel; Trifirò, Gianluca | 2017 | CLINICAL DRUG INVESTIGATION | 1.01 Articolo in rivista | - | |
| 20 | Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? | Raschi E.; Caraceni P.; Poluzzi E.; De Ponti F. | 2020 | EXPERT OPINION ON DRUG SAFETY | 1.04 Replica / breve intervento (e simili) | - |
Copyright © 2021